Allarity Therapeutics, Inc. (ALLR) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 1 Buy, 1 Hold.
Analysts estimate Earnings Per Share (EPS) of $-78.00 and revenue of $0.00B for the next fiscal year.
ALLR Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to Allarity Therapeutics, Inc. in the past 3 months
EPS Estimates — ALLR
%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.00
vs Est –$78.00
▲ 0.0% off
2025
Actual $0.00
vs Est –$0.79
▲ 0.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years.
Revenue Estimates — ALLR
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2025
Actual $0.000B
vs Est $0.049B
▼ 15,078.4% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
